ePrints@IIScePrints@IISc Home | About | Browse | Latest Additions | Advanced Search | Contact | Help

Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: Results of a randomised controlled trial

Bhandari, Nita and Sharma, Pooja and Glass, Roger I and Ray, Pratima and Greenberg, Harry and Taneja, Sunita and Saksena, Manju and Rao, Durga C and Gentsch, Jon R and Parashar, Umesh and Maldonado, Yvonne and Ward, Richard L and Bhan, MK (2006) Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: Results of a randomised controlled trial. In: Vaccine, 24 (31-32). pp. 5817-5823.

[img] PDF
5.pdf - Published Version
Restricted to Registered users only

Download (192Kb) | Request a copy
Official URL: http://www.sciencedirect.com/science?_ob=MImg&_ima...

Abstract

We evaluated safety and immunogenicity of two orally administered human rotavirus vaccine candidates 116E and I321. Ninety healthy infants aged 8 weeks received a single dose of 116E (10(5) FFu (florescence focus units)), 1321 (105 FFu) or placebo. There were no significant differences in the number of adverse events. Fever was reported by 6/30, 1/30 and 5/30 in the 116E, 1321 and placebo groups; the corresponding figures for diarrhoea were 5/30, 8/29 and 3/30. Serum IgA seroconversion rates were 73%, 39% and 20% in the 116E, 1321 and placebo groups, respectively. Vaccine virus was shed on days 3, 7 or 28 in 11/30 infants of the 116E and none in the other two groups. The 116E strain is attenuated, clinically safe and highly immunogenic with a single dose

Item Type: Journal Article
Additional Information: Copyright of this article belongs to Elsavier.
Keywords: Rotavirus vaccine;Safety;Immunogenicity.
Department/Centre: Division of Biological Sciences > Microbiology & Cell Biology
Date Deposited: 08 Apr 2009 08:46
Last Modified: 19 Sep 2010 04:58
URI: http://eprints.iisc.ernet.in/id/eprint/17800

Actions (login required)

View Item View Item